TruBridge (NASDAQ:TBRG) Major Shareholder Pinetree Capital Ltd. Buys 21,035 Shares

TruBridge, Inc. (NASDAQ:TBRG) major shareholder Pinetree Capital Ltd. purchased 21,035 shares of TruBridge stock in a transaction that occurred on Thursday, November 13th. The stock was purchased at an average cost of $20.41 per share, for a total transaction of $429,324.35. Following the completion of the purchase, the insider owned 798,220 shares of the company’s stock, valued at $16,291,670.20. This trade represents a 2.71% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Pinetree Capital Ltd. also recently made the following trade(s):

• On Friday, November 14th, Pinetree Capital Ltd. acquired 18,933 shares of TruBridge stock. The shares were acquired at an average cost of $20.23 per share, for a total transaction of $383,014.59.
• On Wednesday, November 12th, Pinetree Capital Ltd. acquired 8,935 shares of TruBridge stock. The shares were bought at an average cost of $19.94 per share, with a total value of $178,163.90.

TruBridge Stock Down 0.2%

TruBridge stock traded down $0.05 during mid-day trading on Friday, reaching $20.37. The stock had a trading volume of 101,848 shares, compared to its average volume of 147,597. The company has a market capitalization of $305.73 million, a price-to-earnings ratio of -24.25 and a beta of 0.57. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.80 and a quick ratio of 1.79. TruBridge, Inc. has a one year low of $15.40 and a one year high of $32.00. The company has a 50-day moving average price of $20.10 and a two-hundred day moving average price of $21.74.

TruBridge (NASDAQ:TBRG) last released its quarterly earnings data on Thursday, November 6th. The company reported $0.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.48. The business had revenue of $86.11 million for the quarter, compared to analysts’ expectations of $85.56 million. TruBridge had a positive return on equity of 3.30% and a negative net margin of 3.63%. TruBridge has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. On average, analysts expect that TruBridge, Inc. will post 0.07 EPS for the current fiscal year.

Institutional Investors Weigh In On TruBridge

Institutional investors and hedge funds have recently made changes to their positions in the stock. Legal & General Group Plc acquired a new position in TruBridge in the 2nd quarter worth approximately $26,000. First Horizon Corp purchased a new position in TruBridge during the third quarter worth approximately $42,000. Police & Firemen s Retirement System of New Jersey purchased a new position in TruBridge during the second quarter worth about $59,000. New York State Common Retirement Fund acquired a new position in TruBridge in the second quarter valued at about $101,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in TruBridge during the second quarter worth $128,000. 88.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of TruBridge in a research report on Friday, October 31st. BMO Capital Markets initiated coverage on shares of TruBridge in a research note on Thursday. They issued a “market perform” rating and a $19.50 price target on the stock. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $25.50.

TruBridge Company Profile

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.